38,000
Participants
Start Date
August 1, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
July 30, 2028
Cefazolin
administration as outlined
Vancomycin
administered as outlined
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Hamilton Health Sciences Corporation
OTHER